Haderkand colleagues showed that sEVs derived from chronic lymphocytic leukemia (CLL) cells induced monocytes to acquire a skewed pro-tumorigenic phenotype characterized by the increase of cytokine release and PD-L1 expression. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.